✓ Schweizer Online-Shop
Plotkin's Vaccines

Plotkin's Vaccines

von Kathryn M. Edwards, Walter A. Orenstein, Paul A. Offit

Verlag
Elsevier
Unsere Artikel-Nr.
Y254DRR
EAN
9780323790581

Beschreibung

From the latest vaccination evidence, recommendations, and protocols. to new vaccine development and the use of vaccines in reducing disease, Plotkin's Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field. Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization. Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines. Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality. Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues. Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues. Analyzes the cost-benefit and cost-effectiveness of different vaccine options. Helps you clearly visualize concepts and objective data through an abundance of tables and figures. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Spezifikationen

SpracheEnglisch
AutorKathryn M. Edwards, Walter A. Orenstein, Paul A. Offit, Stanley A. Plotkin
ThemaSpezialmedizin: Klinische & Innere Medizin
Auflage8
Erscheinungsjahr2023
FormatBuch (Hardcover)
Anzahl Seiten1734

Inhaltsverzeichnis

"Section 1: General Aspects of Vaccination
1\u00a0A short history of vaccination
2\u00a0Vaccine immunology
3\u00a0Non-specific effects of Vaccines
4\u00a0Correlates of protection
5\u00a0The vaccine industry
6\u00a0Vaccine manufacturing
7\u00a0Evolution of adjuvants across the centuries
8\u00a0Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
9\u00a0Passive immunization
\u00a0Section 2: Licenced Vaccines and Vaccines in Development
10\u00a0General immunization practices
11\u00a0Human Adenovirus vaccines
12\u00a0Anthrax vaccines
13\u00a0EMERGING Diseases and\u00a0 Emerging VACCINES (Military)
14\u00a0Cancer vaccines
15\u00a0Cholera vaccines
16\u00a0Combination vaccines
17\u00a0Coronavirus
18\u00a0Cytomegalovirus vaccines
19\u00a0Dengue vaccines
20\u00a0Diarrhea caused by bacteria
21\u00a0Diphtheria toxoid
22\u00a0Ebola vaccines
23\u00a0Enterovirus
24\u00a0Epstein-Barr virus vaccines
25\u00a0Haemophilus influenzae type b vaccines
26\u00a0Hepatitis A vaccines
27\u00a0Hepatitis B vaccines
28\u00a0Hepatitis C vaccines
29\u00a0Hepatitis E vaccines
30\u00a0Herpes simplex virus vaccines
31\u00a0Human immunodeficiency virus vaccines
32\u00a0Human papillomavirus vaccines
33\u00a0Inactivated influenza vaccines
34\u00a0Influenza vaccine-live
35\u00a0Japanese encephalitis vaccines
36\u00a0Lyme disease vaccines
37\u00a0Malaria vaccines
38\u00a0Measles vaccine
39\u00a0Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines
40\u00a0Meningococcal Capsular B Vaccines
41\u00a0Mumps vaccines
42\u00a0Noninfectious disease vaccines
43\u00a0Norovirus
44\u00a0Norovirus
44\u00a0Parasitic disease vaccines
45\u00a0Pertussis vaccines
46\u00a0Plague vaccines
47\u00a0Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
48\u00a0Pneumococcal polysaccharide vaccines
49\u00a0Poliovirus vaccine-inactivated
50\u00a0Poliovirus vaccine-live
51\u00a0Rabies vaccines
52\u00a0Respiratory syncytial virus vaccines
53\u00a0Rotavirus vaccines
54\u00a0Rubella vaccine
55\u00a0Smallpox and vaccinia
56\u00a0Staphylococcus aureus vaccines
57\u00a0Streptococcus group A vaccines
58\u00a0Streptococcus group B vaccines
59\u00a0Tetanus toxoid
60\u00a0Tick-borne encephalitis virus vaccines
61\u00a0Tuberculosis vaccines
62\u00a0Typhoid fever vaccines
63\u00a0Varicella vaccine
64\u00a0Yellow fever vaccine
65\u00a0Zika vaccine
66\u00a0Zoster vaccine
67\u00a0Technologies for making new vaccines
68\u00a0Section 3: New Technologies
68\u00a0The development of gene-based vectors for immunization
69\u00a0Technologies to Improve Immunization
70\u00a0Vaccination of immunocompromised hosts
71\u00a0Section 4: Vaccination in Special Groups
71\u00a0Vaccines for international travel
72\u00a0Vaccines for health care personnel
73\u00a0Vaccination of pregnant women
74\u00a0Vaccination of pregnant women
74\u00a0Immunization in the United States
75\u00a0Immunization in Europe
76\u00a0Section 5: Public Health and Regulatory Issues
76\u00a0Immunization in the Asia-Pacific region
77\u00a0Immunization in developing countries
78\u00a0Community Protection
79\u00a0Economic analyses of vaccine policies
80\u00a0Regulation and testing of vaccines IN THE US
81\u00a0Regulation of vaccines in Europe
82\u00a0Regulation of vaccines in low and middle-income countries
83\u00a0Vaccine safety
84\u00a0Vaccine hesitancy
85\u00a0Legal issues
86\u00a0Ethics
\u00a0Appendix
\u00a0Foreword"

Bewertungen

Produkt bewerten

Für dieses Produkt liegt noch keine Bewertung vor. Wenn Sie es gekauft haben, teilen Sie gerne Ihre Erfahrung.

Zahlungsarten

payment-einzahlungsscheinpayment-twintpayment-mastercardpayment-visapost-finance-paypayment-apple-paypayment-google-paysamsung-pay

Rechnung (Einzahlungsschein mit QR-Code), Twint, Kreditkarte, PostFinance, Apple, Google oder Samsung Pay.

Versand

Kostenlos: Schweiz & Liechtenstein

Rückgabe

30 Tage Rückgaberecht

Sie können das Produkt innerhalb von 30 Wochentagen ohne Angabe von Gründen zurücksenden, sofern es unbeschädigt und in der Originalverpackung ist.

Weitere Hinweise finden Sie in unseren AGB unter D.1.